Hims & Hers Health Inc. buy Barclays PLC
Start price
08.12.25
/
50%
€33.75
Target price
08.12.26
-
Performance (%)
-17.39%
Price
17.06.26
€27.88
Summary
This prediction is currently active. The price of Hims & Hers Health Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.39%. This prediction currently runs until 08.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | 15.781% | 15.781% |
| iShares Core DAX® | 1.163% | 3.678% |
| iShares Nasdaq 100 | 2.585% | 3.099% |
| iShares Nikkei 225® | 7.111% | 10.600% |
| iShares S&P 500 | 1.261% | 1.669% |
Comments by Barclays_PLC for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Barclays_PLC for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€27.88
17.06.26
17.06.26
-
17.06.27
17.06.27
0.00%
17.06.26
17.06.26
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€22.94
11.03.26
11.03.26
€24.96
11.03.27
11.03.27
21.53%
17.06.26
17.06.26